Literature DB >> 15500042

[The effect of a potential drug ingamine on a model of noninfectious pneumonia].

V L Kovaleva, V E Nebol'sin, O V Makarova, E M Noseĭkina, L P Mikhaĭlova.   

Abstract

The potential drug ingamine (glutarylhistamine) showed pronounced anti-inflammatory activity on a model of acute noninfectious pneumonia and in the stage of chronic inflammation induced by singe instillation of Sephadex (5 mg/kg) in Wistar rats. A 6-day treatment with ingamine (50-500 microg/kg) by inhalation, intragastric, and intraperitoneal administration produced an anti-inflammatory effect (expressed to various degrees), which was manifested by a decrease in alveolitis, bronchitis, obstructive emphysema, lymphocyte-neutrophile infiltration of interalveolar septa, cytosis, and neutrophile component of bronchoalveolar lavage and by normalization of the cytogram. The most pronounced effect was observed upon inhalation in a dose of 500 microg/kg. In the stage of chronic inflammation, the inhalation of ingamine in a dose of 500 microg/kg produced a significant antiinflammatory action for both 10- and 20-day treatment. The effect was comparable with that of the inhaled glucocorticoid budesonide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15500042

Source DB:  PubMed          Journal:  Eksp Klin Farmakol        ISSN: 0869-2092


  1 in total

1.  New Anti-Chemokine Oral Drug XC8 in the Treatment of Asthma Patients with Poor Response to Corticosteroids: Results of a Phase 2A Randomized Controlled Clinical Trial.

Authors:  Julia Romanova; Elena Chikina; Anastasia Rydlovskaya; Wolfgang Pohl; Andreas Renner; Alexey Zeifman; Alexander Chuchalin; Vladimir Nebolsin
Journal:  Pulm Ther       Date:  2020-10-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.